The Trend Architecture
A five-layer market structure, a hardcare/softcare bifurcation, and twelve defining trends organize the operator landscape through 2030.
13. The Five-Layer Market Structure
McKinsey's 2024 wellness research produced the most useful organizational framework for understanding how wellness spending actually flows through the U.S. consumer economy. The market resolves into five distinct layers, each with its own economics, operator types, consumer segments, and strategic imperatives.
Layer One: Everyday Functional Consumption
The largest layer by volume. Food, beverages, supplements, personal care, and daily consumables with a functional-wellness angle.
- SPINS 2025 data: total supplement category growth 7.4%, with standout categories whole-food supplements (+33.6%), hydration/electrolytes (+28.9%), beauty supplements (+28.5%), calmative/mood (+24.3%), minerals (+22.7%)
- Ingredient leaders: magnesium, ashwagandha, creatine, mushrooms (lion's mane, reishi, cordyceps), theanine, colostrum
- Category losers: sleep supplements, weight-loss supplements (cannibalized by GLP-1s), homeopathic remedies
- Retail leaders: Amazon (strongest department growth), Whole Foods, Sprouts, Erewhon, direct-to-consumer (RITUAL, AG1, Thorne, Pique, Needed, Seed)
Dominant operators: AG1 (Athletic Greens), RITUAL, Thorne, Seed (microbiome), Needed (women's), Pique, Cymbiotika, Beam Minerals, Momentous (Huberman-endorsed), Armra (colostrum), Primal Kitchen (Mark Sisson), Bulletproof (Asprey), Kion (Greenfield), Chili (performance).
Business model: DTC subscription dominates premium. Mass retail dominates volume. Typical unit economics: 60%+ gross margins at premium tier, heavy content and creator marketing spend.
Layer Two: Digital Self-Tracking and Interpretation
Wearables, apps, continuous monitors, and the interpretation layer.
- Rock Health 2024: 53% of Americans own a wearable; 54% track at least one health metric digitally
- Oura Ring: 2.5M+ rings sold cumulatively, $5B+ valuation, profitability achieved
- WHOOP: subscription-based ($30/month), significant athlete penetration, $3.6B valuation peak
- Apple Watch: dominant consumer smartwatch, now with ECG, AFib detection, blood oxygen, sleep stages
- Continuous Glucose Monitors for non-diabetics: Dexcom Stelo (launched 2024) and Abbott FreeStyle Libre variants — explosive growth through 2025–2026; NutriSense, Levels, Signos driving subscription layer
- Levels Health: $38M Series A (Andreessen), integration of CGM with nutrition guidance
- Eight Sleep: $150M Series C, smart mattress with thermoregulation and tracking — popular in biohacker community
- ŌURA, Whoop, and Apple are now effectively health-platforms, not just devices
The interpretation layer opportunity: Raw data creates anxiety; interpretation creates value. AI-mediated health intelligence is the fastest-growing sub-category. Platforms like Function Health, Superpower, Heali, and Klarity are moving from pure-data presentation toward actionable recommendations.
Layer Three: In-Person Movement, Recovery, and Mind-Body Services
The physical wellness economy — gyms, studios, spas, recovery facilities, mind-body classes.
- Boutique fitness: ~30% net purchase intent in McKinsey surveys
- Recovery services: cryotherapy (Restore Hyper Wellness, iCRYO, CryoZone), red light therapy (Joovv, BioLight, Sunlighten), compression (NormaTec), massage chains (Massage Envy, Elements)
- Hot/cold contrast: bathhouses (Othership raised $11M Series B 2025, Bathhouse NYC, King Saunas, World Spa Brooklyn), Nordic-style saunas, social sauna clubs
- Mind-body studios: meditation (Unplug, Inscape, The DEN), breathwork (Open, Breathwrk, Soma), yoga (boutique and franchise), cold plunge studios (Plunge, Ice Barrel)
- IV therapy and vitamin infusion clinics: Drip Bar, Restore IV, Reset IV, The IV Doc, Mobile IV Nurses — rapid expansion through 2024–2026
Business model: Membership or subscription dominant. High real estate and staffing costs. Community and experience are core product attributes.
Layer Four: Premium Diagnostics and Longevity Memberships
The high-ticket concierge layer where wellness meets medicine.
- Fountain Life: $21,500 annual Executive Health Membership, 13:1 employer ROI claim, expansion to Houston, LA, Miami
- Function Health: $499/year for 160+ biomarkers, acquired Getlabs in April 2026, passing 200,000 members
- Neko Health: $1.8B valuation, $260M Series B, NYC launch 2026, 300,000+ waitlist
- Love.Life: 45,000 sq ft one-stop campus (John Mackey, Whole Foods founder), diagnostics + functional care + food + spa + fitness
- Life Time / MIORA: 14 athletic country clubs with embedded longevity clinics as of early 2026
- Next Health: franchise model, 150+ locations projected by 2027
- Parsley Health: telehealth functional medicine membership, scaled national footprint
- Humanaut Health: $8.7M seed, new entrant
- Upgrade Labs: Asprey's franchise, expanding nationally
Layer Five: Wellness Environments (Real Estate, Hospitality, Residences)
The layer where wellness is built into the lived environment itself.
- Wellness real estate: $225B (2019) → $548B (2024) → $1.1T (2029) at 15.2% CAGR
- Longevity residences: Velvaere (Park City with Fountain Life), Tri Vananda (Phuket with Clinique La Prairie), The Estate, Elysium Fields (Australia), Canyon Ranch Austin (134 residences)
- Destination resorts: Miraval, Canyon Ranch, Golden Door, Ananda (Himalayas), SHA Wellness Clinic (Spain/Mexico/UAE)
- Luxury hospitality wellness integration: Aman Wellness, Six Senses, Banyan Tree Veya, Equinox Hotels (sleep-optimized rooms)
- European medical longevity destinations: Clinique La Prairie (Switzerland, cellular longevity leader), Lanserhof (Germany, gut-health leader), Chenot Palace Weggis, Buchinger Wilhelmi
Business model: Real estate development with embedded wellness programming. Hospitality with premium wellness layer. High capital intensity; long investment horizons; durable moats.
The Flow Between Layers
Consumers move fluidly between layers. A Maximalist Optimizer might: take daily supplements (Layer 1), track with Oura (Layer 2), train at boutique gym (Layer 3), hold Function Health and Fountain Life memberships (Layer 4), and live in a Canyon Ranch residence (Layer 5). A Health Traditionalist might stop at Layers 1 and 3.
The most valuable operators are those that capture across multiple layers. Love.Life integrates Layers 3 and 4 in a single campus. Life Time integrates Layers 3 and 4 through MIORA. Longevity residences integrate Layers 4 and 5. Function Health integrates Layers 1, 2, and 4 through its supplement, tracking, and biomarker-testing stack.
14. The Hardcare/Softcare Bifurcation
The Global Wellness Summit's Future of Wellness 2026 report identified what may be the single most important strategic distinction in the premium wellness market: the bifurcation between hardcare and softcare.
Hardcare
Quantified, medically-adjacent, optimization-driven. The market for consumers who want their wellness validated by data, delivered by credentialed clinicians, and structured around measurable biomarkers.
- Diagnostics-first (Function Health, Fountain Life, Neko Health)
- Medical and quasi-medical interventions (peptides, hormone optimization, IV therapy, PRP, stem cells)
- Self-quantification (CGMs, wearables, biological age clocks, full-body MRIs)
- Structured protocols (Blueprint, Attia's framework, Huberman's stacks)
- High-intensity training (CrossFit, Barry's, strength-centric gyms)
- Masculine-coded imagery and language (though growing female adoption)
- Aesthetic: clean, white, clinical, tech-forward
Consumer segment primarily: Maximalist Optimizers, Confident Enthusiasts (per McKinsey segmentation).
Operators: Fountain Life, Neko Health, Function Health, Love.Life, Life Time/MIORA, Next Health, Upgrade Labs, Blueprint, Prenuvo, Ezra.
Softcare
Restoration, nervous-system down-regulation, emotional processing, ancient wisdom, community, beauty, intuition. The market for consumers who have rejected or grown weary of the optimization-intensive paradigm.
- Experience-first (retreats, spas, immersions)
- Nervous system and emotional focus (breathwork, meditation, somatic practice)
- Ancient practice (Ayurveda, TCM, yoga, plant medicine)
- Community and belonging (group experiences, shared meals, ritual)
- "Festivalization of wellness" — wellness as celebration rather than regimen
- Feminine-coded aesthetic (though not exclusively female)
- Aesthetic: warm, natural, earthy, beauty-oriented
Consumer segment primarily: a broader cross-section, with particular strength in 40+ women, Maximalist Optimizers who have reached optimization fatigue, and Health Traditionalists seeking accessible alternatives.
Operators: Miraval, Canyon Ranch, Golden Door, Kripalu, Art of Living, Ananda in the Himalayas, SHA Wellness Clinic, Kamalaya, Rythmia (psychedelic), The Ranch Malibu, Sensei, Six Senses Places, Sanctuary Tulum.
The Mid-Market Exposure
Operators stuck in the middle — trying to be partially hardcare and partially softcare — are structurally exposed. The consumer looking for hardcare will find stronger hardcare elsewhere; the consumer looking for softcare will find deeper softcare elsewhere.
Hippocrates Wellness (which appears on the addendum's matrix with 5.3 clinical / 5.6 experience / a raw food detox specialization) is a classic mid-market exposure case: the clinical credibility is below hardcare leaders (Lanserhof 9.3, Clinique La Prairie 9.0, TrueNorth 9.0), and the consumer experience is below softcare leaders (Golden Door 9.3, Ananda 9.0, Aman 8.6, Miraval 8.6).
The strategic path forward for any mid-market operator is to pick a pole and commit — either deepen clinical credibility to compete in hardcare, or deepen emotional and experiential excellence to compete in softcare. The middle does not scale in the 2026–2030 market.
The Converging Edge
Some operators are attempting to integrate both poles in a single offering:
- Canyon Ranch: traditional softcare destination adding more clinical diagnostics
- SHA Wellness Clinic: explicitly integrated hardcare-softcare (medical diagnostics + spa experience)
- Clinique La Prairie: Swiss medical legacy with luxury hospitality delivery
- Lanserhof: German clinical-discipline with 5-star hospitality
- Kamalaya (Thailand): holistic + clinical balance
- Velvaere and Tri Vananda: residential integration of both poles
These integrated operators command premium pricing ($10,000–$50,000/week typical) and represent the emerging "both-and" frontier. But execution is difficult: clinical credibility requires different staff, protocols, and aesthetic than emotional-spiritual experience. Most operators that attempt both end up in the exposed middle rather than on a successfully integrated frontier.
15. Twelve Defining Trends of 2026–2030
The following trends, synthesized from GWS, GWI, McKinsey, NIQ, SPINS, CHPA, and primary industry sources, define the commercial architecture of the parallel health economy through 2030.
Trend 1: The Ovarian-Span Revolution
After two decades of male-indexed longevity protocols, the female reproductive system has been recognized as a central regulator of systemic aging. The ovary ages 2.5x faster than any other organ. The decline of ovarian function accelerates cardiovascular, cognitive, metabolic, and musculoskeletal aging — often 10+ years before clinical menopause.
Market indicators:
- Menopause market: $600 billion by 2030
- Femtech: $63B (2025) → $267B (2035) at 15.5% CAGR
- 1.3M U.S. women enter menopause annually; 54% of women 35–49 actively seeking symptom supplements
- 80% of OB-GYNs lack formal menopause training
Leading operators: Midi Health (telehealth menopause, raised $63M Series B 2025), Elektra Health, Evernow, Peri, Phyla, Alloy Health, Bonafide, Stella (menopause focus in UK/EU), Maven Clinic (broader women's health platform). Legacy: Virginia Hopkins Test Kits, BHRT pellet networks.
Hormone therapy normalization: After two decades of WHI-study-driven skepticism, hormone replacement therapy (now typically bioidentical hormone replacement therapy, BHRT) is being reconsidered. Dr. Mary Claire Haver (The New Menopause), Dr. Heather Hirsch, Dr. Avrum Bluming (Estrogen Matters) are driving clinical and public re-evaluation.
Trend 2: Longevity Real Estate and the Residence Economy
Homes with embedded diagnostics, concierge medicine, circadian lighting, air/water purification, wellness programming, and AI health integration.
- Velvaere (Park City): partnered with Fountain Life for on-site diagnostics and care; residences from $3M
- Tri Vananda (Phuket): partnered with Clinique La Prairie for cellular longevity programming
- The Estate: global network of longevity-programmed residences
- Elysium Fields (Australia): planned community with embedded wellness infrastructure
- Canyon Ranch Austin: 134 residences integrated with the Canyon Ranch wellness program
- Pendry Residences, Aman, Six Senses Places: luxury hospitality-adjacent residential wellness
Traditional developers (Montage, Rosewood, Belmond, Amanyara) are increasingly adding wellness integration as a standard amenity.
Trend 3: The GLP-1 Economic Restructuring
Ozempic, Wegovy, Mounjaro, Zepbound projected to reach ~30 million American users by 2030. This has restructured the wellness market in specific ways:
- Protein and muscle preservation: explosive growth (sarcopenia risk on GLP-1s drives demand for high-protein nutrition, creatine, and strength training)
- Collagen and beauty-health: growth (skin and aesthetic consequences of rapid weight loss)
- Cosmetic procedures: 46% of U.S. consumers spent more on cosmetic procedures in 2024 than 2023; 53% of Gen Z
- "Fauxzempic" natural alternatives: berberine, Pendulum Akkermansia, specific probiotic blends marketed as GLP-1 alternatives
- Anti-GLP-1 wellness positioning: "food as medicine" brands, functional nutrition programs, fitness operators positioning against pharmaceutical weight loss
- GLP-1 concierge programs: telehealth platforms like Hims, Ro, Noom, WeightWatchers providing physician oversight
Trend 4: The Social Wellness Revolution
Wellness as social activity, replacing or augmenting traditional nightlife and bar culture.
- Social bathhouses: Othership ($11M Series B, Toronto/NYC/Boston), Bathhouse (Brooklyn, LA), Remedy Place (LA, NYC, Miami), Alchemy Springs (Austin)
- Sober bars and non-alcohol venues: explosive growth; 92% of non-alcoholic beverage buyers also buy alcohol — the category expands social occasions, doesn't replace them
- Run clubs: reemergence as social-romantic activity; Tracksmith run clubs, NYC running scene
- Breathwork studios and meditation clubs: Unplug, Inscape, The DEN, Open (breathwork)
- Wellness festivals and summits: Wanderlust, Breath Camp, Runga, Further Future, Onsite
The 40-50% decline in alcohol consumption among Gen Z is a major driver of all of these.
Trend 5: The Wearable-to-Interpretation Pipeline
The next frontier is not more sensors; it is better translation of sensor data into actionable guidance.
- AI health intelligence platforms: emerging rapidly; Function Health, Superpower, Heali, Elektra, Klarity building this layer
- Personalized AI coaching: early days, but significant capital inflow; ChatGPT and Claude already being used extensively by biohackers for personal health interpretation
- Continuous multi-parameter monitoring: Oura, Whoop, Apple all moving toward integrated, AI-synthesized daily health briefs
- Medical-grade consumer devices: AFib detection, sleep apnea screening, blood pressure, continuous glucose — blurring the line between wellness and medical device
Trend 6: The Peptide Economy (Detailed in Part V)
A category transformation unfolded 2023–2026: FDA Category 2 restrictions (Sept 2023, 19 peptides), voluntary compliance collapse among consumer gray-market retailers (PeptideSciences.com shut down March 2026), RFK Jr. HHS reclassification of 14 of 19 peptides to Category 1 (February 2026), massive expansion of telehealth peptide clinics, and the maturation of compounded peptide supply through 503A and 503B pharmacies.
Leading peptides in commercial use: BPC-157, TB-500, Sermorelin, Ipamorelin + CJC-1295, Thymosin Alpha-1, PT-141, Melanotan II, Retatrutide (trial), GHK-Cu, NAD+ precursors.
Trend 7: The Biological Age Testing Normalization
Epigenetic clocks have moved from academic research to consumer subscription:
- TruDiagnostic (TruAge): most widely-used consumer epigenetic clock, $229–$499 depending on panel
- Elysium Health Index: epigenetic age + physiological age
- GlycanAge: glycan-based aging biomarker
- InsideTracker: blood-based biological age estimation
- Longevity Technologies PhenoAge / GrimAge: research-grade clocks moving into consumer availability
Typical price range: $200–$500 per test, often quarterly or semi-annual cadence. Consumer market estimated at ~$500M in 2025, projected to reach $2B+ by 2030.
Trend 8: Full-Body Imaging Goes Mainstream
Full-body MRI screening moved from controversy to commercial explosion:
- Prenuvo: full-body MRI scan, $2,500+, partnered with Kim Kardashian and celebrity endorsements, 15+ locations
- Ezra: full-body MRI, $1,950+, Series B raised in 2024
- Neko Health: full-body scan approach (not MRI, but multi-parameter optical/thermal/biometric), $260M raised
- Fountain Life: integrated full-body MRI into executive health memberships
The clinical evidence (1.57% pooled cancer detection rate per 2025 meta-analysis, high incidental finding burden) continues to be debated. Commercial demand is growing regardless — consumers are buying the reassurance and early-warning positioning, and operators are expanding capacity to meet demand.
Trend 9: Plant Medicine and Psychedelic-Assisted Therapy Mainstream Arrival
- FDA approvals advancing: Compass Pathways psilocybin Phase 3 for PTSD (accepted January 7, 2026); MDMA-assisted therapy NDA resubmission expected 2026 after 2024 FDA setback
- Ketamine clinics: ~600+ U.S. ketamine-assisted therapy clinics operational; Mindbloom, Field Trip, Numinus leading
- Legal psilocybin retreats: Jamaica, Netherlands, now Oregon (licensed program operational), Colorado (program launching 2026)
- Ayahuasca and ibogaine medical tourism: Costa Rica, Mexico, Peru
- Corporate and executive adoption: growing; Mindscape Retreat, Synthesis, Behold Retreats targeting tech/executive market
Market projections: $8.5B (2026) → $26B (2034) for psychedelic drugs; considerably larger when plant medicine retreat economy and ketamine clinics included.
Trend 10: Exit from Allopathic Primary Care
- Direct Primary Care practices: 2,500–2,700 nationally, growing 241% from 2017–2021
- Concierge medicine membership: ~1.5–2M Americans
- HSA eligibility for DPC (January 2026): up to $150/month individual, $300/month family
- Oregon HB 2540: insurers must credit cash payments toward deductibles (January 2026)
- Functional medicine practitioners (IFM-certified): ~4,000+ globally, doubling every ~4 years
Trend 11: The Founder-Physician Category
A new category of physicians have exited traditional practice to build cash-pay consumer brands:
- Peter Attia — Attia Medical, Early Medical, The Drive podcast
- Mark Hyman — Function Health, UltraWellness Center, Cleveland Clinic functional medicine
- Craig Koniver — Koniver Wellness (peptides)
- Gabrielle Lyon — Institute for Muscle-Centric Medicine
- Molly Maloof — Maloof, longevity consulting, women's metabolic health
- Amy Shah — I♥ My Hormones
- Mary Claire Haver — Galveston Diet, The New Menopause
- William Li — Eat to Beat Disease
- David Perlmutter — Grain Brain franchise
Each has built a brand-plus-practice hybrid that bridges credentialed medicine with the consumer sovereign-health movement.
Trend 12: AI-Mediated Longevity Intelligence
Emerging as a category in 2026: AI platforms specifically designed for personal health interpretation, supplement stacking, biomarker analysis, and protocol recommendation.
- Claude, ChatGPT, Perplexity: widely used informally by biohackers
- Purpose-built platforms: Function Health's AI layer, Superpower, 20+ startups in development
- Home-lab + AI: kits like Biomarker Health, combining DTC blood testing with AI interpretation
- Expected trajectory: AI-mediated longevity intelligence will become a $5B+ category by 2030
16. Women's Longevity and the Ovarian-Span Paradigm
The single largest structural re-rating in the wellness industry through 2030 is the recognition that women's longevity requires its own framework — not a derivative of male-indexed research.
The Biological Foundation
- Ovarian aging begins in the early 30s, accelerates through the 40s, and produces the dramatic hormonal shifts of perimenopause and menopause from ~45–55
- Estrogen's systemic effects include protection of cardiovascular, cognitive, skeletal, and metabolic systems; its decline accelerates aging across multiple domains
- Testosterone in women (produced primarily by the ovaries and adrenals) declines significantly during midlife, with effects on libido, muscle mass, energy, and mood
- Progesterone plays critical roles in sleep, mood, and nervous system regulation
The Commercial Opportunity
Specific categories compounding at 15–25%+ annually:
- Hormone replacement therapy and bioidentical hormone replacement therapy (BHRT)
- Peri- and menopause-focused supplements (sleep, hot flash, cognitive, joint)
- Menopause telehealth (Midi, Evernow, Elektra, Alloy, Peri)
- Weight-bearing strength training programming specifically designed for perimenopausal and postmenopausal women
- Pelvic floor and sexual health (pleasure tech, pelvic floor therapy)
- Cognitive support (nootropics, brain health programs)
- Beauty-from-within specifically marketed at midlife women
- Ovarian reserve assessment and fertility longevity
Key Operators and Voices
- Midi Health — telehealth menopause, $63M Series B 2025
- Alloy Health — menopause-specific telehealth
- Evernow, Elektra Health, Peri — direct-to-consumer menopause support
- Dr. Mary Claire Haver — The New Menopause, viral content driver
- Dr. Heather Hirsch — Harvard-affiliated menopause specialist, educator
- Dr. Avrum Bluming — Estrogen Matters, co-authored with Carol Tavris
- Dr. Rachel Rubin — sexual medicine, hormone advocacy
- Dr. Mary Louder — functional hormone medicine
- Oprah & Maria Shriver (The Osbournes collaboration) — mainstream attention driver
The Strategic Implications
For operators:
- Any wellness operator not offering menopause-specific programming will be strategically exposed by 2028
- Longevity clinics serving women cannot use male protocols without modification (testosterone ranges, BHRT approaches, ovarian reserve testing, iron/ferritin considerations, autoimmune screening)
- Real estate and residences serving 45+ demographics must incorporate menopause-sensitive design (temperature control for hot flashes, circadian and sleep optimization)
17. Longevity Residences and Wellness Real Estate
The Market Scale
- Global wellness real estate: $225B (2019) → $548B (2024) → $1.1T (2029) at 15.2% CAGR
- U.S. wellness real estate: roughly 45% of global, or ~$250B in 2024
- Growth driver: pandemic-era home-as-sanctuary behavior permanently altered consumer preferences; GLP-1 and aging-in-place trends compound
Category Emergence: "Longevity Residences"
A new sub-category has emerged in 2024–2026: residences explicitly designed and marketed around embedded longevity programming, diagnostics, and medical access.
Leading properties:
Velvaere (Park City, Utah) — Full-service longevity community partnered with Fountain Life for on-site diagnostics, biomarker tracking, and care coordination. Residences from $3M. Full wellness programming including fitness, recovery, nutrition, and spa.
Tri Vananda (Phuket, Thailand) — Longevity residences partnered with Clinique La Prairie. 200+ residences planned. Integrates Swiss cellular longevity protocols with Thai hospitality.
The Estate — Global network brand being built around premium longevity residences.
Elysium Fields (Australia) — Planned longevity-integrated community, Gold Coast.
Canyon Ranch Austin — 134 residences integrated with the Canyon Ranch wellness operation, launching 2024–2026.
Prana Del Mar (Cabo, Mexico) — Closing June 10, 2026 (Kaleidoscope Ventures advisory) — boutique longevity community.
Adjacent Categories
Active adult / 55+ longevity-oriented communities:
- Latitude Margaritaville (Jimmy Buffett brand, multiple locations)
- The Villages (Florida)
- Sun City (Del Webb brand)
- Traditional 55+ communities increasingly layering wellness programming
Wellness-integrated hospitality residences:
- Montage Residences (Laguna Beach, Kapalua, Deer Valley, Cabo, Palmetto Bluff)
- Four Seasons Private Residences
- Ritz-Carlton Residences
- Rosewood Residences
- Aman Residences
- Six Senses Places (Residences Dubai, NYC, etc.)
- Pendry Residences (Montage Hotels sister brand)
Urban wellness-integrated developments:
- Lake Nona (Orlando) — Chopra Mind-Body Zone, Tavistock-developed wellness city
- Serenbe (Atlanta) — wellness-oriented planned community
- Babcock Ranch (FL) — solar + wellness community
- Welltower's communities — wellness-integrated senior living
The Strategic Context
Wellness real estate is transitioning from amenity to operating system. The most sophisticated developers now view wellness programming as integral to the property's operational identity, not as a spa attached to the lobby. This has implications:
- Operating costs: higher, but supported by membership/service revenue
- Design requirements: circadian lighting, water/air quality, thermal optimization, movement integration, community spaces
- Programming requirements: ongoing wellness, fitness, nutrition, social curation
- Partnerships: with clinical operators (Fountain Life, MIORA, Next Health), hospitality operators (Canyon Ranch, Miraval), technology platforms (Eight Sleep, Dyson purification)
For Mr. Deven's Overabove client portfolio, this is the exact intersection where luxury real estate marketing expertise and deep understanding of the longevity ecosystem create defensible advisory positioning. Alys Beach, Montage, Southern Land Company, and similar clients are all potential beneficiaries of integrated longevity-residence positioning.
18. The Wearable-to-Interpretation Pipeline
Rock Health's 2024 survey established the foundational numbers: 53% of Americans own at least one wearable or connected health device; 54% track at least one health metric digitally.
This is sufficient penetration to say self-monitoring is now normal behavior — not a hobby, not a niche.
Where the Sensors Are Today
- Smart watches: Apple Watch dominant, Samsung Galaxy Watch, Garmin (athletic/outdoor), Fitbit (now Google/Alphabet)
- Rings: Oura dominant (~3M+ lifetime units), Ultrahuman, Samsung Galaxy Ring
- Chest straps and wristbands: Whoop, Polar, Coros
- CGMs for non-diabetics: Dexcom Stelo, Abbott Lingo, NutriSense, Levels, Signos
- Sleep tracking: Eight Sleep (mattress), Oura, Whoop, Apple Watch, Withings Sleep Mat
- Bioimpedance scales: Withings Body+, Renpho, Garmin Index
- Smart scales with body composition: InBody, Tanita, Eufy
- ECG/cardiac: Apple Watch, KardiaMobile, Withings Scanwatch
- Blood pressure: Omron, Qardio, Withings BPM
- DNA/microbiome: 23andMe (now under restructuring), Nebula Genomics, Viome, Zoe
- Blood biomarkers: Function Health, InsideTracker, Everlywell, Thorne testing, LetsGetChecked
The Problem: Data Without Interpretation
The raw data creates anxiety without clarity. A consumer looking at their HRV, their glucose curves, their sleep stages, their VO2max, their blood markers, and their biological age has no unified framework for what to do. The market is moving from sensors to sense-making.
The Interpretation Layer Emerging
AI-driven health intelligence is the fastest-growing sub-category:
- Function Health: integrates lab results with AI recommendations; acquired Getlabs (April 2026) to scale
- Superpower: subscription concierge layer on top of consumer testing
- Heali: AI nutrition interpretation layered on CGM and wearable data
- Klarity: AI-driven integrative health recommendations
- Momentum: emerging AI health coach
- OpenAI ChatGPT and Anthropic Claude: used informally by millions of consumers for personal health interpretation — often more helpful than the raw data alone
The commercial opportunity through 2030: the platform that successfully synthesizes wearable data + blood markers + genetic data + lifestyle inputs + symptom reporting into a unified, personalized, actionable daily brief will capture an enormous market. This is analogous to what Bloomberg is to finance: the interpretation layer that sits above all the data sources and makes them actionable.
19. Social Wellness, Third Places, and Festivalization
The Demographic Driver
Gen Z and millennials have dramatically shifted social behavior:
- ~50% reduction in alcohol consumption among Gen Z vs. prior generations
- Rise of sober-curious and moderation movement
- Decline of bar and nightclub culture in major urban markets
- Loneliness epidemic (HHS has formally identified it as a public health crisis)
- Remote work has eliminated the office as a default "third place"
The result: a structural reallocation of social spending from alcohol-based venues to wellness-based venues.
The Social Wellness Operator Landscape
Bathhouses and thermal contrast venues:
- Othership (Toronto, NYC, Boston): $11M Series B 2025, communal sauna + cold plunge with group programming
- Bathhouse (Williamsburg, Flatiron, LA): premium social bathhouse
- Remedy Place (LA, NYC, Miami): social bathhouse + IV therapy + biohacking tech
- World Spa (Brooklyn): large-format Eastern European-inspired social bathhouse
- King Saunas, SPA Castle, and legacy Korean/Russian bathhouses
Sober bars and non-alcohol social venues:
- Listen Bar (NYC), Hekate (NYC), Getaway (NYC), Sans Bar (Austin) — sober-only
- The Brink (SF), Absence of Proof — expanding
- Growing "dry January" and "sober curious" movement year-round
Run clubs and movement communities:
- Tracksmith's run club network
- NYC run club scene (November Project, Mile High Run Club, Dashing Whippets)
- Boutique run studios (Mile High Run Club, Form 50, STRIDE, Equinox's running programs)
Breathwork and meditation clubs:
- Open (breathwork studio, LA/NYC)
- Inscape (NYC meditation club)
- Unplug (LA meditation)
- The DEN (LA, NYC)
- Breathwrk, Othership, Soma (app-based + in-person)
Social fitness studios with wellness integration:
- Barry's, SoulCycle, Orangetheory, Peloton (studio format)
- Life Time (integrated club + MIORA longevity)
- Equinox (with Equinox Hotels expansion)
- Crunch Fitness Longevity (lower-ticket access)
The Festivalization of Wellness
Wellness has increasingly adopted festival formats — immersive, multi-day, community-based experiences that combine programming with social identity:
- Wanderlust (yoga festival network)
- Lightning in a Bottle (music + wellness integration)
- Runga (wellness retreat + music)
- Further Future (tech + wellness festival)
- Burning Man's decompressed wellness sub-communities
- A-Fest (wellness + entrepreneurship)
- Breath Camp (intensive breathwork)
- Boss Babe retreats, Align retreats, She Summit
The Strategic Implication
The third place is being rebuilt around wellness rather than alcohol. Operators that can create durable community around wellness activities — whether through bathhouses, run clubs, studios, retreats, or festivals — are building the cultural infrastructure that the next generation of healthy, long-lived Americans will inhabit.
For real estate developers, this suggests that wellness-integrated social spaces (bathhouses, studios, outdoor recreation, community gardens, event spaces) are increasingly important programmatic elements of premium properties.
20. The GLP-1 Economic Restructuring
Each spoke is an adjacent category reshaped by the GLP-1 wave. Green indicates accelerated; red indicates cannibalized.
The Scale
McKinsey's 2024 metabolic health research projected that by 2030, approximately 30 million Americans could be on GLP-1 medications for obesity or overweight. This is an order-of-magnitude larger than the existing population on these drugs for diabetes alone.
The drugs: Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide). New generations: Retatrutide (triple agonist, Lilly Phase 3), oral GLP-1s (Rybelsus expansion), and others.
The Wellness Market Impact
GLP-1s have not cannibalized the wellness market — they have restructured it. The specific effects:
Accelerated categories:
- Protein: consumers on GLP-1s must prioritize protein to preserve lean mass against accelerated weight loss. Protein powders, high-protein foods, and animal-protein-adjacent products have boomed.
- Creatine and strength supplementation: preserve muscle mass
- Collagen and beauty-from-within: address skin laxity consequences
- Cosmetic procedures: address loose skin — "Ozempic face," "Ozempic butt" driving surgery, filler, and skin tightening
- High-quality nutrition programs: ensure nutrient density despite reduced caloric intake
- Strength training: preserve and build muscle
- Supplements addressing muscle loss: HMB, leucine, whey isolate
Decelerated categories:
- Traditional weight loss supplements: dramatic decline (SPINS shows weight-loss category declining)
- Fat burners and thermogenics: largely cannibalized
- Some meal replacement and diet food: impacted as consumers no longer need appetite-suppression in food form
- Traditional diet plans: Weight Watchers acquired Sequence to move into GLP-1 provision; Noom and Jenny Craig pivoted
Adjacent growth:
- "Fauxzempic" natural alternatives: berberine (significant YoY growth), Pendulum Akkermansia (probiotic), specific fiber-protein products marketed as GLP-1 alternatives
- GLP-1 compounding and gray market: compounded semaglutide through 503A/503B pharmacies (legal during shortage declarations), shifting regulatory landscape
- Microdosing GLP-1s for longevity: emerging biohacker practice; non-obese consumers using low-dose semaglutide or tirzepatide for metabolic-health benefits, inflammation reduction, and putative longevity effects
- GLP-1 concierge programs: Hims, Ro, Noom, Steady MD, telehealth platforms delivering physician oversight
The Longevity Hypothesis
A significant wing of the biohacker community now views GLP-1s as a longevity intervention in their own right — citing effects on cardiovascular risk (confirmed in SELECT trial), kidney function, liver fat, inflammation, and potentially cognitive function. Semaglutide's effects on multiple organ systems, not just weight, have positioned it as a candidate for a "statin-of-longevity" general preventive medication.
The commercial expression: micro-dosing protocols (0.25–0.5mg/week for non-obese users) are increasingly discussed in biohacker communities, prescribed by functional medicine physicians, and supplied by compounding pharmacies. This is controversial, generally off-label, and represents a classic parallel-economy adaptation of a pharmaceutical product.
The Strategic Synthesis
GLP-1s have demonstrated that the parallel economy and the pharmaceutical economy are not adversaries — they are increasingly integrated. Consumers stack GLP-1s with peptides, with supplements, with functional medicine protocols, with wearables, with longevity memberships. The wellness operators that acknowledged this reality early (Function Health, Fountain Life, Parsley Health all incorporating GLP-1 management into their membership offerings) have outperformed operators that positioned "anti-GLP-1" as their stance.
The lesson for 2026–2030: the next wave of pharmaceutical innovations (next-generation GLP-1s, senolytic drugs, epigenetic reprogramming therapies, AI-designed peptides) will be integrated into parallel-economy offerings faster than the institutional system can regulate or the pharmaceutical industry can distribute. The wellness operators most strategically positioned are those that treat themselves as the integrators of the full emerging stack, not as the defenders of a "natural" alternative to pharmaceutical intervention.